Ramadsibir, the only drug approved for treatment in Europe, will arrive in the country after the inventory is almost run out • Worldwide distribution is done according to the plague situation in each country

• Ramdsibir

  Photo: 

  IPI

Inventory of the drug Ramdsibir is expected to arrive in Israel this week, the only drug approved in Europe to treat Corona. This, after the inventory has almost run out in recent times. This is how Sunday evening became known for "Israel Today".

Israel was one of the first countries that the drug, which Gilead manufactures, came to. The drug will now arrive in the country according to the availability of inventory worldwide. And the division between countries is done according to the state of the epidemic (the epidemic) in each country (some patients per 1,000 people).

Last month, a study on the drug - done in critically ill patients and a control group - found that providing five days of treatment increased 65 percent of patients' chances of improving disease symptoms and metrics - hospital discharge and blood oxygen levels. The treatment seems to be helpful for the symptoms of the disease but it has not yet proven effective in the mortality index.

In the group that received Ramdesibir treatment for 10 days, there was a 31% improvement in the chance of improvement in clinical symptoms. However, the improvement is not significant.